You need to be logged in to view this video
Since inception Emerald has focused on developing cannabis based medicines, backed by clinical efficacy, with standard dosing and conventional delivery mechanisms. This presentation will cover how Emerald plans to achieve this goal, in a differentiated take on the burgeoning cannabis industry.
Avtar Dhillon
Emerald Health Therapeutics,
Executive Chairman
Avtar Dhillon is a life sciences entrepreneur with more than 20 years' experience building public companies through mergers and acquisitions, leading innovation in scientific, engineering, and farming enterprises, securing government grants and NGO funding (more than $75 million US to date), and building dominant IP portfolios through partnering. During his tenure as president and CEO at Inovio (NASDAQ: INO), he led the turnaround of the company through restructuring and acquisitions.
Trending Now
Filter By Category
Filter By Keywords
Loading...